JP2006515886A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515886A5 JP2006515886A5 JP2006501021A JP2006501021A JP2006515886A5 JP 2006515886 A5 JP2006515886 A5 JP 2006515886A5 JP 2006501021 A JP2006501021 A JP 2006501021A JP 2006501021 A JP2006501021 A JP 2006501021A JP 2006515886 A5 JP2006515886 A5 JP 2006515886A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- hydrogen
- alkoxy
- propyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44087303P | 2003-01-17 | 2003-01-17 | |
| US44391103P | 2003-01-30 | 2003-01-30 | |
| PCT/US2004/001279 WO2004064741A2 (en) | 2003-01-17 | 2004-01-20 | Compounds, compositions, and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006515886A JP2006515886A (ja) | 2006-06-08 |
| JP2006515886A5 true JP2006515886A5 (https=) | 2006-10-19 |
Family
ID=32776034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501021A Pending JP2006515886A (ja) | 2003-01-17 | 2004-01-20 | 化合物、組成物、および方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20070149500A1 (https=) |
| EP (1) | EP1594849A4 (https=) |
| JP (1) | JP2006515886A (https=) |
| WO (1) | WO2004064741A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| US6794379B2 (en) | 2001-06-06 | 2004-09-21 | Tularik Inc. | CXCR3 antagonists |
| WO2003070701A2 (en) | 2002-02-15 | 2003-08-28 | Cytokinetics, Inc. | Syntheses of quinazolinones |
| US7214800B2 (en) | 2002-05-09 | 2007-05-08 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| CA2485148A1 (en) | 2002-05-09 | 2003-11-20 | Cytokinetics, Inc. | Pyrimidinone compounds, compositions and methods |
| EP1513820A4 (en) | 2002-05-23 | 2006-09-13 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| WO2003106426A1 (en) | 2002-06-14 | 2003-12-24 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| AU2003256805A1 (en) | 2002-07-23 | 2004-02-09 | Cytokinetics, Inc. | Compounds compositions and methods |
| WO2004034972A2 (en) | 2002-09-30 | 2004-04-29 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| WO2004113335A2 (en) * | 2003-06-20 | 2004-12-29 | Chiron Corporation | Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| JP2007510652A (ja) * | 2003-11-03 | 2007-04-26 | サイトキネティクス・インコーポレーテッド | ピリミジン−4−オン化合物、組成物、および方法 |
| EP1692112A4 (en) | 2003-12-08 | 2008-09-24 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS, AND METHODS |
| ATE419249T1 (de) * | 2004-04-06 | 2009-01-15 | Novartis Vaccines & Diagnostic | Inhibitoren von mitotischem kinesin |
| RU2007106552A (ru) * | 2004-07-22 | 2008-08-27 | Астразенека Аб (Se) | Конденсированные пиримидоны, пригодные для лечения и предотвращения злокачественного новообразования |
| CN101027309B (zh) | 2004-08-18 | 2010-10-27 | 阿斯利康(瑞典)有限公司 | 所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途 |
| EP1856128A4 (en) * | 2005-01-19 | 2009-12-23 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINE |
| CA2593166A1 (en) * | 2005-01-19 | 2006-07-27 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| CA2612585A1 (en) | 2005-06-27 | 2007-01-04 | Amgen Inc. | Anti-inflammatory aryl nitrile compounds |
| JP2009514866A (ja) * | 2005-11-02 | 2009-04-09 | サイトキネティクス・インコーポレーテッド | ある種の化学物質、組成物、および方法 |
| AU2008205169B2 (en) | 2007-01-05 | 2012-02-02 | Novartis Ag | Imidazole derivatives as kinesin spindle protein inhibitors (Eg-5) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3609598A1 (de) * | 1986-03-21 | 1987-10-01 | Hoechst Ag | 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
| CA2465491A1 (en) * | 2001-11-07 | 2003-05-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| EP1513820A4 (en) * | 2002-05-23 | 2006-09-13 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
| AU2003256805A1 (en) * | 2002-07-23 | 2004-02-09 | Cytokinetics, Inc. | Compounds compositions and methods |
| US20040024596A1 (en) * | 2002-07-31 | 2004-02-05 | Carney Laurel H. | Noise reduction system |
| US20040048853A1 (en) * | 2002-08-21 | 2004-03-11 | Gustave Bergnes | Compounds, compositions, and methods |
-
2004
- 2004-01-20 WO PCT/US2004/001279 patent/WO2004064741A2/en not_active Ceased
- 2004-01-20 EP EP04703589A patent/EP1594849A4/en not_active Withdrawn
- 2004-01-20 US US10/541,441 patent/US20070149500A1/en not_active Abandoned
- 2004-01-20 JP JP2006501021A patent/JP2006515886A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006515886A5 (https=) | ||
| JP2005523312A5 (https=) | ||
| RU2004133325A (ru) | Соединения, композиции на их основе и способы их использования | |
| CA2413426A1 (en) | Methods and compositions utilizing quinazolinones | |
| ES2705077T3 (es) | Moduladores de receptores opioides | |
| CN100491358C (zh) | 嘧啶酮类化合物、组合物及方法 | |
| CN103649093B (zh) | 取代的咪唑并吡啶和咪唑并哒嗪及其用途 | |
| AU2009264431B2 (en) | Pyrazolo-quinazolines | |
| RU2009132605A (ru) | Производные 5,6,7,8-тетрагидроптеридина в качестве ингибиторов hsp90 | |
| AU679608B2 (en) | Imidazodiazepines | |
| JP2014503534A5 (https=) | ||
| CA2866213A1 (en) | Substituted azabicycles and use thereof | |
| AU2003300255A1 (en) | Substituted pyrrolo-pyrazole derivatives as kinase inhibitors | |
| CA2792725A1 (en) | Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd | |
| NZ515501A (en) | Use of pyrazolo[4,3-d]pyrimidin-7-ones, pyrazolo[3,4-d]pyrimidin-4-ones, quinazolin-4-ones, purin-6-ones, pyrido[3,2-d]pyrimidin-4-ones and tetracyclic derivatives to treat nitrate-induced tolerance | |
| MY139344A (en) | 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists | |
| KR20230010729A (ko) | 단독 요법 및 병용 요법 | |
| CA2747326A1 (en) | Combination of aurora kinase inhibitors and anti-cd20 antibodies | |
| AU2009252220A1 (en) | Inhibitor of analgesic tolerance | |
| JP2021518379A5 (https=) | ||
| CN102665700A (zh) | 治疗实体瘤和其它恶性肿瘤的方法和组合物 | |
| US20050220705A1 (en) | Methods for treating non-melanoma cancers with PABA | |
| EP2036909A1 (en) | Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof | |
| CN101415426A (zh) | c-Src抑制剂与嘧啶基氨基苯甲酰胺类化合物的组合治疗白血病的用途 | |
| RU2005114491A (ru) | Соединения, составы и способы их использования |